ABVC BioPharma, Inc.(ABVC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ABVC ABVC BioPharma, Inc.

Market Closed 02-27 16:00:00 EST

1.31

+0.02

+1.55%

盘后1.31

+0.000.00%

17:51 EST

High1.31	Low1.18	Vol83.37K
Open1.29	D1 Closing1.29	Amplitude10.08%
Mkt Cap33.31M	Tradable Cap26.98M	Total Shares25.42M
T/O103.80K	T/O Rate0.40%	Tradable Shares20.60M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"ABVC","market":"US","secType":"STK","nameCN":"ABVC BioPharma, Inc.","latestPrice":1.31,"timestamp":1772226000000,"preClose":1.29,"halted":0,"volume":83367,"hourTrading":{"tag":"盘后","latestPrice":1.31,"preClose":1.31,"latestTime":"17:51 EST","volume":164,"amount":214.645,"timestamp":1772232660861,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.015503875968992262,"floatShares":20595500,"shares":25423700,"eps":-0.20892826,"marketStatus":"Market Closed","change":0.02,"latestTime":"02-27 16:00:00 EST","open":1.29,"high":1.31,"low":1.18,"amount":103798.75943070001,"amplitude":0.100775,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.20892826,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772442000000},"marketStatusCode":7,"adr":0,"listingDate":1627963200000,"exchange":"NASDAQ","adjPreClose":1.29,"preHourTrading":{"tag":"盘前","latestPrice":1.28,"preClose":1.29,"latestTime":"09:15 EST","volume":2348,"amount":3014.3241276000003,"timestamp":1772201715397,"change":-0.01,"changeRate":-0.007752,"amplitude":0.007752},"postHourTrading":{"tag":"盘后","latestPrice":1.31,"preClose":1.31,"latestTime":"17:51 EST","volume":164,"amount":214.645,"timestamp":1772232660861,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.9783233097309958,"impliedVol":1.8394,"impliedVolPercentile":0.7632},"requestUrl":"/m/hq/s/ABVC/wiki","defaultTab":"wiki","newsList":[{"id":"2614857342","title":"I told my boss I need an ADHD coach and his response was unhelpful. Can we fix our working relationship?","url":"https://stock-news.laohu8.com/highlight/detail?id=2614857342","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614857342?lang=en_us&edition=fundamental","pubTime":"2026-02-27 23:03","pubTimestamp":1772204580,"startTime":"0","endTime":"0","summary":"'I feel like I'm just in shut-down and discouraged mode'. \"I don't know how to deal with a boss who wants me to improve, but gets frustrated if I ask any questions.\" . My background is in partnerships and nonprofits, and I was hired for philanthropy. They thought my skills could transfer, which they can. However, my boss's feedback is always rude and discouraging. It has been challenging. There's so much jargon, and things are constantly happening. Everyone around me said, \"It's going to take you a minute to learn.\" That first year, though, I had many moments with my boss where he seemed impatient with me for not catching on quickly. He told me to ask questions if I didn't know something, but when I did, he would say, \"I feel like we talked about this.\". 'I suggested we get an ADHD coach, and he said we don't have the budget.'. If you're just starting out on your money or career journey and have questions about how to navigate your finances, we want to hear from you. Write to Dollar Si","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADHD","ABVC","BK4139"],"gpt_icon":0},{"id":"2614362138","title":"Axsome Explores Solriamfetol In Phase 3 CLARITY Trial For MDD Subset","url":"https://stock-news.laohu8.com/highlight/detail?id=2614362138","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614362138?lang=en_us&edition=fundamental","pubTime":"2026-02-27 17:41","pubTimestamp":1772185272,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics (NasdaqGM: AXSM) has started the CLARITY Phase 3 trial of solriamfetol in major depressive disorder with excessive daytime sleepiness.\nThe trial focuses on a group of MDD patients who experience excessive daytime sleepiness, for which no approved treatments are currently available.\nThis study expands Axsome's clinical program into an area of unmet medical need.\n\nAxsome Therapeutics, listed on the NasdaqGM under the ticker AXSM, develops therapies for central nervous...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-explores-solriamfetol-in-phase-3-clarity-trial-for-md","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-axsm/axsome-therapeutics/news/axsome-explores-solriamfetol-in-phase-3-clarity-trial-for-md","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","AXSM","BK4139","BK4505","ABVC","BK4007"],"gpt_icon":0},{"id":"2610681438","title":"Yukiguni Maitake Sets Medium-Term Plan and Outlines FY2026 Q3 Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2610681438","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610681438?lang=en_us&edition=fundamental","pubTime":"2026-02-09 14:59","pubTimestamp":1770620344,"startTime":"0","endTime":"0","summary":"YUKIGUNI MAITAKE CO., LTD. ( ($JP:1375) ) has issued an update. YUKIGUNI MAITAKE CO., LTD. released an outline of its performance review for the th...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/yukiguni-maitake-sets-medium-term-plan-and-outlines-fy2026-q3-review?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/yukiguni-maitake-sets-medium-term-plan-and-outlines-fy2026-q3-review?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2610689892","title":"Yukiguni Maitake Sees FY Net Y2.01B","url":"https://stock-news.laohu8.com/highlight/detail?id=2610689892","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610689892?lang=en_us&edition=fundamental","pubTime":"2026-02-09 14:31","pubTimestamp":1770618660,"startTime":"0","endTime":"0","summary":"Yukiguni Maitake Co. Ltd. also released the following forecasts:. This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2609807035","title":"ABVC Biopharma Inc. Announces Date for Upcoming Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2609807035","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609807035?lang=en_us&edition=fundamental","pubTime":"2026-02-06 06:30","pubTimestamp":1770330636,"startTime":"0","endTime":"0","summary":"ABVC BioPharma Inc. has announced that it will hold its annual meeting of shareholders virtually on March 9, 2026. During the meeting, shareholders will be asked to consider and vote on the re-election of the current director nominees to serve on the company's Board of Directors until the next annual shareholders meeting and until their successors are duly elected and qualified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABVC Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on February 05, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL87wwgy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139"],"gpt_icon":0},{"id":"2608385162","title":"Aytu BioPharma reports Q2 EPS ($1.05) vs. 13c last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2608385162","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608385162?lang=en_us&edition=fundamental","pubTime":"2026-02-04 05:50","pubTimestamp":1770155430,"startTime":"0","endTime":"0","summary":"Reports Q2 revenue $15.2M vs. $16.2M last year. Revenue was impacted by a deemphasis in marketing for the ADHD and pediatric portfolios as the comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aytu-biopharma-reports-q2-eps-1-05-vs-13c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aytu-biopharma-reports-q2-eps-1-05-vs-13c-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2605496400","title":"In My Forties I Found Out I Have ADHD -- Maybe You Do Too -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2605496400","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605496400?lang=en_us&edition=fundamental","pubTime":"2026-01-24 04:00","pubTimestamp":1769198400,"startTime":"0","endTime":"0","summary":"Are you, or is someone you know, \"so ADD\"?Welcome to the club. I don't actually endorse membership. I say this as someone who learned a year ago, in my forties, that I have ADHD .Actual statistics on ADHD are indeed pretty staggering: a 2024 survey found that 25% of adults suspect they have it. The fastest growing cohort being diagnosed is adult women. From 2020 to 2022, the diagnosis rate nearly doubled among women aged 23 to 49.Are Instagram algorithms poisoning the masses by rattling off symptoms associated with ADHD that most people have to some extent -- like having a hard time motivating to do laundry?Social media is one of the most commonly used sources for mental health information. Posts about ADHD on TikTok have been viewed somewhere in the neighborhood of 28 billion times .I'd noticed the impact of technology on my attention but I'd always thought of myself as overly focused, fixated on things even. I once stayed up until 2 a.m. reading Ted Kennedy's testimony about what hap","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","ADHD","BK4139"],"gpt_icon":0},{"id":"2604491909","title":"ABVC Biopharma Issues Amendment to Recent SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2604491909","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604491909?lang=en_us&edition=fundamental","pubTime":"2026-01-17 05:31","pubTimestamp":1768599079,"startTime":"0","endTime":"0","summary":"ABVC Biopharma Inc. has filed an amendment to its current report on Form 8-K/A, originally reported on April 30, 2025. The amended filing includes references to a purchase agreement and a voting rights proxy agreement, with CEO Uttam Patil signing the document on January 16, 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ABVC Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 16, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nNDLc0hXb9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2603457600","title":"Collegium to Present Four Real-World Data Posters at APSARD 2026 Annual Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2603457600","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603457600?lang=en_us&edition=fundamental","pubTime":"2026-01-15 21:00","pubTimestamp":1768482000,"startTime":"0","endTime":"0","summary":"STOUGHTON, Mass., Jan.  15, 2026  (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced it will have four poster presentations highlighting real-world data from its ADHD pr","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/15/3219495/34897/en/Collegium-to-Present-Four-Real-World-Data-Posters-at-APSARD-2026-Annual-Conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4023","BK4135","BK4585","HCP","BK4139","CNS","CII","BK4588","ADHD"],"gpt_icon":0},{"id":"2603612821","title":"Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD","url":"https://stock-news.laohu8.com/highlight/detail?id=2603612821","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603612821?lang=en_us&edition=fundamental","pubTime":"2026-01-14 22:00","pubTimestamp":1768399200,"startTime":"0","endTime":"0","summary":"Four weeks of non-invasive DIFS neurostimulation delivers meaningful attention gains alongside objective brain imaging changesHOUSTON, TX, Jan.  14, 2026  (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/14/3218706/0/en/Published-Peer-Reviewed-Study-Demonstrates-Nexalin-s-DIFS-Neurostimulation-Improves-Attention-and-Normalizes-Brain-Activity-in-Patients-with-ADHD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0031619046.USD","IE00B66KJ199.SGD","MEG","ADHD","BK4120","IE00B19Z4B17.USD","LU2308191902.HKD","IE00B7SZL793.SGD","ABVC","BK4139"],"gpt_icon":0},{"id":"2602512710","title":"BrainsWay Announces FDA Approval of Neurolief’s Proliv™Rx Neuromodulation System for Major Depressive Disorder (MDD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2602512710","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602512710?lang=en_us&edition=fundamental","pubTime":"2026-01-12 20:30","pubTimestamp":1768221000,"startTime":"0","endTime":"0","summary":"BrainsWay’s strategic investment in Neurolief paved the way for the first and only FDA approved at-home neuromodulation device with Class III Premarket Approval labeling for MDD patients who failed on","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/12/3216761/17676/en/BrainsWay-Announces-FDA-Approval-of-Neurolief-s-Proliv-Rx-Neuromodulation-System-for-Major-Depressive-Disorder-MDD.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ABVC"],"gpt_icon":0},{"id":"2601869041","title":"Ark Biopharmaceutical Receives China Marketing Authorization for Azstarys® for the Treatment of ADHD","url":"https://stock-news.laohu8.com/highlight/detail?id=2601869041","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601869041?lang=en_us&edition=fundamental","pubTime":"2026-01-06 14:45","pubTimestamp":1767681900,"startTime":"0","endTime":"0","summary":"Figure 1. Each Azstarys capsule contains 70% SDX and 30% d-MPH . Robust Clinical Data Addresses Unmet Need:In a pivotal Phase III clinical trial in Chinese patients with ADHD, Azstarys met both the primary and key secondary endpoints. The study demonstrated statistically significant and clinically meaningful improvements in core ADHD symptoms compared to placebo at all assessment time points. With limited treatment options in China and historical supply constraints for traditional single-agent therapies, the approval of this innovative combination product offers an important new choice for clinicians and patients.Unique Dual Mechanism for Rapid Onset and All-Day Coverage:Azstarys combines immediate-release and prodrug-based extended-release technologies. Its'rapid onset + full-day coverage'profile positions it to reshape the ADHD treatment paradigm in China. As thefirst ADHD medication in China to deliver both rapid onset and sustained sy","market":"hk","thumbnail":"https://mma.prnewswire.com/media/2855260/AK0901_EN.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/2855260/AK0901_EN.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/ark-biopharmaceutical-receives-china-marketing-authorization-for-azstarys-for-the-treatment-of-adhd-302653543.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139","SDX.AU","ADHD"],"gpt_icon":0},{"id":"1139437794","title":"Luo Yonghao Discloses ADHD Diagnosis: May Cease Large-Scale Events if Medication Change Fails or Physical Condition Issues Persist","url":"https://stock-news.laohu8.com/highlight/detail?id=1139437794","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139437794?lang=en_us&edition=fundamental","pubTime":"2025-12-31 09:20","pubTimestamp":1767144048,"startTime":"0","endTime":"0","summary":"On December 31, Luo Yonghao revealed in a Weibo post that he has long been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). Luo Yonghao stated that due to his ADHD, none of his product...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","ADHD","BK4139"],"gpt_icon":0},{"id":"2593812433","title":"How sport and athletes can show the realities of neurodiversity","url":"https://stock-news.laohu8.com/highlight/detail?id=2593812433","media":"cityam","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593812433?lang=en_us&edition=fundamental","pubTime":"2025-12-21 18:41","pubTimestamp":1766313705,"startTime":"0","endTime":"0","summary":"SOUTHEND, ENGLAND - JULY 28: A fan holds a sign dedicated to Lucy Bronze as spectators wait for the England Women's Squad to arrive back at Southend Airport on July 28, 2025 in Southend, England. England defeated Spain in the UEFA Women's EURO 2025 Final to retain the trophy on 27 July.  Sport and athletes like Simone Biles, Lewis Hamilton and Lucy Bronze can play a key role in reframing attitudes on neurodiversity, writes Matt Readman.Earlier this month Wes Streeting announced a review into how the UK is currently diagnosing mental health conditions, jumping on the bandwagon of those questioning whether normal feelings have become “over-pathologised”.Part of this review will include a closer look at neurodiversity, and in particular ADHD and autism.According to NHS England data, diagnoses of both these conditions have almost tripled in the last decade. This has led to claims that we are unnecessarily over-diagnosing neurodiversity, particularly ADHD, which saw Personal Independence Pa","market":"us","thumbnail":"https://www.cityam.com/wp-content/uploads/2025/12/GettyImages-2227368264-e1766313588548.jpg?w=824&h=463&crop=1","type":0,"news_type":0,"thumbnails":["https://www.cityam.com/wp-content/uploads/2025/12/GettyImages-2227368264-e1766313588548.jpg?w=824&h=463&crop=1"],"rights":{"source":"cityam_highlight","url":"https://www.cityam.com/how-sport-and-athletes-can-show-the-realities-of-neurodiversity/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.cityam.com/how-sport-and-athletes-can-show-the-realities-of-neurodiversity/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"cityam_highlight","symbols":["PIP","BK4139","ABVC"],"gpt_icon":0},{"id":"2590953409","title":"Grant Cardone Says ADHD Isn't A Disorder But 'Misunderstood Genius' — It's A 'Gift From God' That Helps People Chase Multiple Passions","url":"https://stock-news.laohu8.com/highlight/detail?id=2590953409","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590953409?lang=en_us&edition=fundamental","pubTime":"2025-12-11 02:01","pubTimestamp":1765389660,"startTime":"0","endTime":"0","summary":"Grant Cardone isn't exactly known for keeping things subtle. The high-octane real estate mogul and motivational speaker has long made headlines with his unapologetically bold takes, and his views on mental health labels are no exception. This time, he's turning ADHD and bipolar disorder on their heads—insisting they're not disorders at all, but misdiagnosed brilliance.In November, Cardone posted a video to his official Facebook page with the caption: \"ADHD is just misunderstood genius.\". In the clip, Cardone appears on camera during an interview, explaining his belief that society pathologizes traits it doesn't understand. \"ADD, ADHD, bipolar—all these manic kind of people—they've been labeled something negative by some fake doctor,\" he said.To be clear, Cardone may wear many hats—investor, author, speaker—but none of them are \"doctor.\" He's not advising anyone to skip their meds or ignore real diagnoses. Many p","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/10/Grant-Cardone--Elena-Lyons-Cardone-At-Th.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/10/Grant-Cardone--Elena-Lyons-Cardone-At-Th.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/topics/25/12/49313663/grant-cardone-says-adhd-isnt-a-disorder-but-misunderstood-genius-its-a-gift-from-god-that-helps-people-chase-multiple-passions","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/topics/25/12/49313663/grant-cardone-says-adhd-isnt-a-disorder-but-misunderstood-genius-its-a-gift-from-god-that-helps-people-chase-multiple-passions","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["ADHD","BK4139","ABVC","BK4109","CCF"],"gpt_icon":0},{"id":"2590318095","title":"China Resources Double-Crane Pharmaceutical's ADHD Capsules Included in China's Insurance Catalog","url":"https://stock-news.laohu8.com/highlight/detail?id=2590318095","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590318095?lang=en_us&edition=fundamental","pubTime":"2025-12-09 15:29","pubTimestamp":1765265362,"startTime":"0","endTime":"0","summary":"Chinese authorities included the dextromethorphan hydrochloride sustained-release capsules manufactured by China Resources Double-Crane Pharmaceutical  subsidiary Henan Zhongshuai Pharmaceutical in the country's national insurance drug catalog.The drug is used as a psychostimulant for attention deficit hyperactivity disorder and nodular disorders in children aged 6 and above, according to a Tuesday filing with the Shanghai bourse.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK0185","ABVC","BK0175","BK0028","BK0239","BK4139","BK0010","600062","BK0188","ADHD"],"gpt_icon":0},{"id":"2586649185","title":"Tonix Pharma’s IND Clearance Boosts MDD Treatment Efforts","url":"https://stock-news.laohu8.com/highlight/detail?id=2586649185","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586649185?lang=en_us&edition=fundamental","pubTime":"2025-11-25 01:06","pubTimestamp":1764003994,"startTime":"0","endTime":"0","summary":"Tonix Pharma ( ($TNXP) ) has shared an update. On November 24, 2025, Tonix Pharmaceuticals announced that the FDA cleared their IND application for...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/tonix-pharmas-ind-clearance-boosts-mdd-treatment-efforts?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/tonix-pharmas-ind-clearance-boosts-mdd-treatment-efforts?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ABVC","IND"],"gpt_icon":0},{"id":"2585012982","title":"When ADHD Meds Are Just the Start -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2585012982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585012982?lang=en_us&edition=fundamental","pubTime":"2025-11-22 05:57","pubTimestamp":1763762220,"startTime":"0","endTime":"0","summary":"This is an edition of the WSJ Weekend Reads newsletter, a weekly look at our most colorful, thought-provoking and original feature stories on the business of life. If you're not subscribed, sign up here.Danielle Gansky was 7 years old when she started taking medication for ADHD. By her late 20s, she had taken 14 different kinds of psychiatric pills.Tens of thousands of kids who take prescription ADHD medication like Danielle did also wind up on other powerful psychotropic drugs. This week, we have an in-depth look at this trend of childhood overmedication and its lasting effects.\"I was living in a body hijacked by the medication,\" says Danielle, who at 29 still is struggling to wean herself off an antidepressant.Other topics that we delve into include trans-Atlantic cruises, the new \"Wicked\" movie and the joy of doing nothing in retirement.Enjoy your weekend with these and all the great reads below.Many children who are prescribed medication for ADHD end up taking other powerful psychi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139","ADHD"],"gpt_icon":0},{"id":"2585141502","title":"For Kids, ADHD Pills Are Often Just the Start -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2585141502","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585141502?lang=en_us&edition=fundamental","pubTime":"2025-11-21 22:55","pubTimestamp":1763736900,"startTime":"0","endTime":"0","summary":"This is an edition of the WSJ Health newsletter, a weekly briefing on what's new in health, medicine, personal well-being and the business of healthcare. If you're not subscribed, sign up here.The newsletter won't publish the Friday after Thanksgiving. Your next edition will arrive the following week. Enjoy the break!For many kids, ADHD pills are the start of a drug cascade. The next steps are often powerful psychotropic drugs -- including antipsychotics, antidepressants and sleep aids -- even though their combined effects in young children haven't been studied closely.Separately, the founder of an ADHD startup was found guilty of conspiracy. Ruthia He, whose company Done Global was the subject of a WSJ investigation, was accused of orchestrating a scheme to profit from Adderall prescriptions.Trump administration officials discussed curbing the role of the FDA commissioner, Marty Makary, after complaints about his management style, though the idea was dropped.The FDA called for the rem","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADHD","BK4139","ABVC"],"gpt_icon":0},{"id":"2584034809","title":"Millions of Kids Are on ADHD Pills. For Many, It's the Start of a Drug Cascade. -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2584034809","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584034809?lang=en_us&edition=fundamental","pubTime":"2025-11-20 10:00","pubTimestamp":1763604000,"startTime":"0","endTime":"0","summary":"By Shalini Ramachandran,Betsy McKay and Tom McGinty | Design by Audrey Valbuena. Danielle Gansky was 7 years old when an administrator at her upscale private girls' school in suburban Philadelphia flagged problems with her academic performance. She was a bubbly and creative kid, but she was easily distracted in class and her schoolwork was sloppy.More pills followed. Over the years, Gansky was always on two and sometimes three or more psychiatric drugs at once. By her late 20s, she had taken 14 different kinds of psychiatric pills.None of it ever felt right. The pills dulled her mind and made her irritable or sleepy. But when Gansky complained about the drugs, her doctors would up her dose or try another medication.\"I was living in a body hijacked by the medication,\" said Gansky, 29, who is still struggling to wean herself off an antidepressant. \"I didn't have the words or authority to challenge what I was being told.\". The Journal compared about 166,000 children aged 3 to 14 who start","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABVC","BK4139","ADHD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.abvcpharma.com","stockEarnings":[{"period":"1week","weight":-0.1325},{"period":"1month","weight":-0.3544},{"period":"3month","weight":-0.5166},{"period":"6month","weight":-0.5371},{"period":"1year","weight":0.6416},{"period":"ytd","weight":-0.385}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1703, which is in Phase II clinical trials for the treatment of metastatic pancreatic cancer; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; ABV-1601 that is in Phase I/II clinical trials for treating depression in cancer patients; ABV-1701 Vitargus that is in Phase II clinical trials for the treatment of retinal detachment or vitreous hemorrhage; and ABV-1519, which is in Phase I/II clinical trials for the treatment of non-small cell lung cancer. ABVC BioPharma, Inc. has a co-development agreement with Rgene Corporation; and collaboration agreements with BioHopeKing Corporation and BioFirst Corporation. The company is based in Fremont, California. ABVC BioPharma, Inc. is a subsidiary of YuanGene Corporation.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.072395},{"month":2,"riseRate":0.125,"avgChangeRate":-0.057705},{"month":3,"riseRate":0.714286,"avgChangeRate":0.083622},{"month":4,"riseRate":0.285714,"avgChangeRate":0.004516},{"month":5,"riseRate":0.428571,"avgChangeRate":-0.011992},{"month":6,"riseRate":0.285714,"avgChangeRate":1.316596},{"month":7,"riseRate":0.428571,"avgChangeRate":-0.097297},{"month":8,"riseRate":0.5,"avgChangeRate":-0.054488},{"month":9,"riseRate":0.375,"avgChangeRate":-0.065685},{"month":10,"riseRate":0.375,"avgChangeRate":-0.067045},{"month":11,"riseRate":0.625,"avgChangeRate":0.051458},{"month":12,"riseRate":0.5,"avgChangeRate":-0.012195}],"exchange":"NASDAQ","name":"ABVC BioPharma, Inc.","nameEN":"ABVC BioPharma, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ABVC BioPharma, Inc.(ABVC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ABVC BioPharma, Inc.(ABVC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ABVC BioPharma, Inc.,ABVC,ABVC BioPharma, Inc.股票,ABVC BioPharma, Inc.股票老虎,ABVC BioPharma, Inc.股票老虎国际,ABVC BioPharma, Inc.行情,ABVC BioPharma, Inc.股票行情,ABVC BioPharma, Inc.股价,ABVC BioPharma, Inc.股市,ABVC BioPharma, Inc.股票价格,ABVC BioPharma, Inc.股票交易,ABVC BioPharma, Inc.股票购买,ABVC BioPharma, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ABVC BioPharma, Inc.(ABVC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ABVC BioPharma, Inc.(ABVC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction